Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. (Q35842144)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

main subject

metastatic breast cancer

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

A J Clayton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

S Danson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

S Jolly

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

W D J Ryder

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

P A Burt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

A L Stewart

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

P M Wilkinson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

R S Welch

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

B Magee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

G Wilson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

A M Wardley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

language of work or name

English

0 references

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

639-643

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

HER2 testing and correlation with efficacy of trastuzumab therapy.

30 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

The role of overexpressed HER2 in transformation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

The basic biology of HER2.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

Chemotherapy induces regression of brain metastases in breast carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

The natural history of breast cancer patients with brain metastases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

Gamma knife radiosurgery for brain metastases: a primary therapeutic option

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

The role of prophylactic cranial irradiation in the treatment of lung cancer

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

Central nervous system metastasis from breast carcinoma. Autopsy study

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364775

Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer

24 September 2018

1 reference

12 December 2020

1 reference

12 December 2020

Patterns of disease spread in metastatic breast carcinoma: influence of estrogen and progesterone receptor status

1 reference

12 December 2020

Metastatic breast cancer with HER2/neu-positive cells tends to have a morbid prognosis

1 reference

12 December 2020

Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601970

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

PubMed publication ID

15266327

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15266327%20AND%20SRC:MED&resulttype=core&format=json